Bausch Health. has filed a patent for a method of treating onychomycosis, a fungal infection of the nails. The method involves applying a 10% efinaconazole formulation once a day for at least 36 weeks without removing the formulation or debriding the nail. The formulation includes various ingredients such as water, alcohol, and citric acid. The patent also describes the use of an applicator for administering the formulation to the affected area. GlobalData’s report on Bausch Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Bausch Health, Cancer treatment biomarkers was a key innovation area identified from patents. Bausch Health's grant share as of September 2023 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
The patent is filed for a method of treating onychomycosis
A recently filed patent (Publication Number: US20230293508A1) describes a method for treating onychomycosis, a fungal infection of the toenails. The method involves using a container with an applicator to dispense and spread a formulation containing efinaconazole, an antifungal medication, to the affected area. The formulation includes various ingredients such as alcohol, cyclomethicone, and antioxidants.
The method outlined in the patent involves loading the applicator with the efinaconazole formulation and manually spreading it onto each affected toe. The container can be a multiple-use container, and the method is recommended to be repeated daily for at least 4 weeks. The patent also mentions the option of manually loading the applicator with the formulation.
The container described in the patent is a squeeze-sensitive container, and the applicator is a flow-through applicator that dispenses the formulation when pressure is applied. The method can be performed for a duration of at least 36 weeks, with a recommended duration of 48 weeks.
The patent provides options for the type of applicator to be used, including a brush, pad, swab, sponge, or roller. The volume of formulation contained in the applicator is specified to be about 75 to 150 microliters.
The method does not involve cutting the nails more frequently than once every two weeks. Additionally, the efinaconazole formulation is not administered in an occluded or semi-occluded manner, and there is no requirement to remove the formulation from the treatment area during the treatment period. Debridement of the nail or nail-associated tissue is also not necessary.
The formulation may contain water, and the average amount of efinaconazole delivered to each square centimeter of the treatment area is specified to be between 0.15 mg/cm2 and 0.45 mg/cm2.
The patent claims that the performance of this method in a patient population can result in a mycological cure rate of at least 40%, a clinical efficacy rate of at least 20%, and a complete cure rate of at least 10%, or a combination of these rates.
Overall, this patent describes a method for treating onychomycosis using an efinaconazole formulation applied with a specific type of container and applicator. The method does not involve cutting nails frequently or using occlusive techniques, and it aims to achieve high cure rates in patients.
To know more about GlobalData’s detailed insights on Bausch Health, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
